#Biopreservation market size

[latestmarketresearchnews]

Biopreservation Market Growth Drivers With Outlook And Opportunity Forecast To 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.

Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.

Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.

Product Segmentation Insights:

The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.

The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Biopreservation Industry Analysis, Opportunities And Forecast Report, 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.

Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.

Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.

Product Segmentation Insights:

The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.

The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

Biopreservation Industry – Analysis, Industry Size And Forecast, 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private…

[tbrcresearchreport]

The Business Research Company offers biopreservation market market research report 2023 with industry size, share, segments and market growth

[insightslicelive]

Biopreservation Market Trends Analysis, Size, Key Insights and Overview by 2032 | Atlanta Biologics, Lifeline Scientific, LabVantage Solutions

Biopreservation Market Trends Analysis, Size, Key Insights and Overview by 2032 | Atlanta Biologics, Lifeline Scientific, LabVantage Solutions

The Global Biopreservation Market 2023 to 2032 report provides details of new recent developments, trade regulations, import-export intelligence, supply chain balance, share, the impact of domestic and localized market players, opportunities in terms of emerging revenue pockets, changes in market regulations, strategic growth analysis, size, category growths, application niches and dominance,…

[organicmarketresearch1]

Global Biopreservation Market Size, Share, Trends, Growth & Industry 2032

Global Biopreservation market size was USD 3.11 billion in 2023 and the market is projected to touch USD 23.73 billion by 2032, at a CAGR of 25.33 % during the forecast period. Biopreservation refers to keeping alive of biological samples, cells, tissues and organs in a state of stability through cooling or freezing them so as to prolong their shelf life and retain their quality for use in future. It is very important to different sectors such as healthcare, pharmaceuticals and R&D where there is need for such materials to be kept for conducting tests or treatments or even transplanting an organ. Biopreservation market is made up of various types of products and services aimed at making this process easier including specialized storage devices, chemicals used for preventing spoilage known as cryoprotectants together with solutions which keep them alive known as preservation media among others which fall under sample management aspects or transport in different ways or even departments in specific institutions.

Recent years have witnessed a substantial increase in the global biopreservation market owing to a number of different factors. Demand for specific drugs and treatments coupled with regenerative surgeries that necessitate personal data storage on life supporting materials is one primary force creating an impact on this trend. Moreover, there is growing rates of chronic illnesses development along with rising counts of organ transplant procedures which has led to the demand for efficient biopreservation methods. However, obstacles like regulations, ethics, and expensive storage facilities seem to be preventing the market from growing. The global biopreservation market is projected to grow in the future as research into improving biopreservation techniques continues and their application area broadens, this will provide an opportunity for those concerned in healthcare industries.

Global Biopreservation report scope and segmentation.

Report Attribute

Details

Base Year

2023

Forecast Years

2024–2032

Estimated Market Value (2023)

USD 3.11 Billion

Projected Market Value (2032)

USD 23.73 Billion

Segments Covered

By Product, By Application Area, By End User, & By Region.

Forecast Units

Value (USD Million or Billion)

Quantitative Units

Revenue in USD million/billion and CAGR from 2024 to 2032.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, GCC Countries, and South Africa, among others.

Download Free Sample Report

Global Biopreservation dynamics

There are several key factors driving the biopreservation market, one of which is increase in the demand for personalized medicine and regenerative therapies. This results in the necessity to preserve individualized biologic samples. This means that as more precise treatments are being designed for specific patients, there is an urgent need for proven biopreservation techniques to keep these samples. Furthermore, numerous other factors account for the expanding market for biopreservation solutions which is promoted by the increasing number of patients with chronic conditions as well as growing organ transplantations globally. Many people are now in need of long-term treatment such as regular medical care, then this implies a rise in the use of conserved living things for scientific study, detection, and treatment.

Similarly, biotechnology and cell therapy research can change the biopreservation market. Furthermore, given that stem cell therapy and gene editing present new opportunities, protecting biological samples is given much attention to aid in continuous research and development efforts. The world is driven by the need for new biopreservation technologies and services designed to preserve various biological materials alive and functioning. Moreover, these collaborations among academia, industry and government have played a significant role in enhancing knowledge sharing, resource availability, funds provision among others in order to support research on biopreservation.

Get Complete Report: https://organicmarketresearch.com/global-biopreservation-market

Global Biopreservation drivers

Rise in Personalized Medicine

Biopreservation market gains a lot due to the strong spike in favour of personalized medicine a medical trend that involves tailoring treatments to the individual patient’s genetic composition. This form of medicine calls for storing bodily fluids taken from a patient for future use during diagnosis or research. The rise in awareness about genetic factors determining disease susceptibility and response to treatments leads to a growing need for biopreservation solutions to hold these examples. This phenomenon does not only encourage the utilization of biopreservation techniques in health care, but also brings together biobanks with research organizations and pharmaceutical firms in order to create targeted treatments.

Advancements in Biotechnology

The demand for innovative biopreservation solutions is driven by continuous advancements in biotechnology especially in cell therapy, regenerative medicine, and tissue engineering areas. Maintaining the viability and functionality of live cells and tissues used for new therapeutic modalities being explored in the research community requires specific approaches in their preservation. Induced pluripotent stem cells (iPSCs) have revolutionized research into effective therapies. They need precise cryopreservation procedures, however, for the cell to remain intact when stored or defrosted. In view of the above, biopreservation industry stakeholders should anticipate an upward trajectory as biology burgeons and advanced therapeutics demand top of the range conservation methods.

Restraints:

Regulatory Constraints

Regulatory compliance is indeed a challenge that the market of biopreservation is facing more so regarding the storage and transportation of biological samples. As a result of these regulations and guidelines put in place, preserved specimens have to be handled, labelled and documented in accordance with stringent measures which in turn make operations in biopreservation expensive and complex. Observing international standards such as Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) is key but can pose a challenge to smaller players or players operating in multiple jurisdictions.

High Cost of Specialized Equipment

The expensive characteristic of specified biopreservation equipment like ultra-low temperature freezers, automated storage systems and cryopreservation tanks have been an enormous obstacle to market expansion. It requires a lot of funds to establish and keep running biobanks or biorepositories that have latest facilities for preservation purposes. Additionally, the present operational costs like energy consumption and maintenance increases the cost hence limiting access to advanced solutions for biopreservation especially in low-resource contexts.

Opportunities:

Expansion of Biobanking Initiatives

The increasing focus on personalized medicine and biomolecular exploration will provide opportunities for expanding global biobanking endeavours. Biobanks are essential in scientific studies, particularly in sample preservation which boosts the need for bio-preservation solutions. By creating complete biobanking networks, it will allow biopreservation providers to offer their services and technologies which have been facilitated by collaborative efforts among academic institutions, healthcare organizations and government agencies.

Segment Overview

By product, the biopreservation market is segmented into Equipment, and Biopreservation Media. Equipment includes a range of devices used for the storage and preservation of biological samples, such as ultra-low temperature freezers, liquid nitrogen tanks, and automated storage systems. These products create environments that are carefully controlled which help maintain the condition of cells, tissues, and organs for extended periods. Also, biopreservation media refers to solutions or mixtures created specifically for safeguarding biological matter from various agents while still allowing storage or shipment. Usually within them are found anti-freezes as well as anti-oxidants together with other preservatives used in order to reduce injury imposed by such process as low temperature maintenance on living cells.

By application, the biopreservation market is segmented into drug discovery, biobanking, regenerative medicine, and other application areas. In drug discovery, biopreservation plays a crucial role in preserving cell lines, tissues, and biological samples used in screening assays, pharmacokinetic studies, and toxicity testing. Biobanking includes the collection, storage and distribution of biological specimens for research, clinical trials or diagnostic objectives, thus leading to an overwhelming demand for dependable biopreservation solutions which can preserve the integrity of samples. In regenerative medicine the conservation of stem cells, tissues and organs is a prerequisite for the production of new therapies to replace damaged tissues in patients. Biopreservation, besides, is also utilized in agriculture, veterinary medicine and environmental research where there is a demand for keeping samples for a long duration period to aid in scientific study as well as other works.

Global Biopreservation Overview by Region

With its well-established healthcare facilities, extensive research and development projects, as well as huge investments into biotechnology and pharmaceutical industries, North America is the leading market in the world. Biobanks, academic institutions and industry counterparts in collaboration have led to cutting edge innovations in biopreservation technologies and service delivery in this area. Initiatives promoting personalized medicine, regenerative therapies and biobanking networks as well as stringent regulatory standards has made Europe to follow closely in order to ensure the quality and safety of biopreserved samples which in turn fosters trust among stakeholders. The Asia Pacific region can undergo a swift expansion, arising from an upsurge of healthcare expenditure in this fast-growing industry, development of biopharmaceuticals and increased attention to preservation of living organisms in medicine. China, Japan, India, among others are putting up facilities for storing samples and studying preserved organisms in order to keep pace with rising needs of the developing countries. Furthermore, emerging economies in Latin America and the Middle East & Africa are witnessing rising investments in healthcare infrastructure and research capabilities, presenting untapped opportunities for market expansion.

Global Biopreservation market competitive landscape

The competitive landscape of the biopreservation market is identified by the presence of several key players, including Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, BioLife Solutions Inc., and Avantor Inc. These companies dominate the market through their extensive product portfolios, strong distribution networks, and strategic partnerships. They focus on innovation to develop advanced biopreservation solutions that meet the evolving needs of healthcare, pharmaceutical, and research industries. Additionally, mergers and acquisitions play a significant role in influencing the competitive factors, enabling companies to expand their market presence and enhance their capabilities in biopreservation technologies and services. In addition, the biopreservation domain is being penetrated by small companies and new market participants who offer narrow specialized products for certain uses or market segments. This increases competition and prompts larger corporations that wish to remain competitive to spend more on R&D activities.

Global Biopreservation Recent Developments

November 2023, BioLife Solutions announced a fundraising of USD 10.4 million through a private placement by Casdin Capital. The funds are intended to support ongoing operations related to biopreservation media and other offerings.

October 2022, Azenta, Inc. completed the acquisition of B Medical Systems S.á r.l and its subsidiaries. B Medical Systems is renowned for providing temperature-controlled storage and transportation solutions crucial for delivering life-saving treatments worldwide.

July 2022, the inauguration of Cellutions BioStorage took place in Chennai, India. As a research-to-launch Cryopreservation Bank, Cellutions BioStorage offers comprehensive biomaterial storage and logistics services. It caters to biopharmaceutical firms seeking to outsource supply chain management throughout a product’s life cycle. The newly opened facility spans 25,000 square feet and boasts state-of-the-art infrastructure.

Contact Us: Mob : +91 9319642100 Noida One Tower Sec 62 Noida 201301 Sales : sales@organicmarketresearch.com Website : https://www.organicmarketresearch.com

[insightfulblogz]

Biopreservation Market Type, Dynamics, and Industry Analysis by 2032

Biopreservation is an innovative method used to enhance the shelf life and safety of food products and pharmaceuticals through the use of natural or controlled microbiota and their by-products. This approach leverages the inherent properties of microorganisms, such as lactic acid bacteria, yeasts, and molds, to inhibit the growth of spoilage and pathogenic organisms, thereby maintaining product quality and safety. As global demand for safe, high-quality food products and pharmaceuticals continues to rise, biopreservation offers a sustainable alternative to synthetic preservatives, aligning with the increasing consumer preference for clean-label products that emphasize natural ingredients.

In the biotechnology sector, biopreservation plays a crucial role in the storage and transportation of biological materials, such as cell lines, tissues, and organ transplants. By employing biopreservation techniques, such as cryopreservation and controlled freezing, researchers and medical professionals can extend the viability of these materials, ensuring their effectiveness for therapeutic applications. With advancements in technology and growing awareness of the benefits of biopreservation, the field is poised for significant growth as it meets the evolving demands of the food and pharmaceutical industries.

The Biopreservation Market size was estimated at USD 2.82 billion in 2023 and is expected to reach USD 9.6 billion by 2032 at a CAGR of 28.4% during the forecast period of 2024-2032.

Future Growth

The biopreservation market is set to experience robust growth in the coming years, driven by increasing consumer awareness regarding food safety and quality, as well as the rising demand for biopreserved pharmaceuticals. As health-conscious consumers seek products free from artificial additives, manufacturers are turning to biopreservation techniques to extend shelf life while adhering to clean-label standards. Additionally, the increasing trend towards functional foods and nutraceuticals, which often require effective preservation methods to maintain bioactivity, further enhances the prospects for biopreservation.

Furthermore, the growing emphasis on sustainability within the food industry is propelling interest in biopreservation methods. By reducing food waste and extending the shelf life of products without compromising quality, biopreservation aligns with environmental goals and consumer preferences. The pharmaceutical sector is also witnessing a shift towards biopreservation as biobanks and tissue banks expand to store biological samples for research and therapeutic applications. As regulatory agencies continue to support biopreservation techniques and technologies, the market is anticipated to expand significantly over the next decade.

Drivers

Several factors are driving the growth of the biopreservation market. One of the primary drivers is the increasing incidence of foodborne illnesses and contamination, which has heightened consumer awareness and regulatory scrutiny regarding food safety. Biopreservation methods, utilizing natural microorganisms, provide an effective means of mitigating these risks and ensuring the safety of food products. As consumers prioritize health and safety, manufacturers are increasingly adopting biopreservation techniques to enhance their product offerings and build consumer trust.

Another significant factor is the expanding pharmaceutical sector, which relies heavily on biopreservation techniques for the storage and transport of biological materials. With the rise of personalized medicine and advanced therapies, the demand for biopreserved cells, tissues, and organs is escalating. Biopreservation not only ensures the longevity of these materials but also maintains their functional integrity, making it an essential component of modern biopharmaceutical research and development. Moreover, the growing trend towards sustainable practices in both food and pharmaceuticals has further fueled interest in biopreservation, as these methods align with environmental and health-conscious initiatives.

Key Takeaways

Biopreservation enhances the safety and shelf life of food products and pharmaceuticals using natural microorganisms.

The market is driven by increasing consumer awareness of food safety, demand for clean-label products, and the need for effective preservation methods in pharmaceuticals.

Key players like DuPont and BASF SE are leading the development of innovative biopreservation solutions that cater to industry needs.

The rising prevalence of foodborne illnesses and the expansion of the pharmaceutical sector are significant drivers for the biopreservation market.

Sustainable practices and the demand for functional foods and nutraceuticals are further propelling the adoption of biopreservation techniques.

Get a Free Sample Copy of the Report: https://www.snsinsider.com/sample-request/3792 

Conclusion

As the global focus on health, safety, and sustainability continues to grow, the biopreservation market is positioned for substantial growth. With its ability to enhance product quality and extend shelf life without relying on artificial additives, biopreservation represents a viable solution for both the food and pharmaceutical industries. The advancements in biopreservation technologies, coupled with increasing regulatory support, are driving innovation and expanding applications across various sectors.

In a world that prioritizes safety, quality, and sustainability, biopreservation emerges as a vital strategy to address modern challenges in food safety and biotechnology. By harnessing the power of natural microorganisms and innovative preservation techniques, biopreservation not only improves the viability of products but also aligns with consumer preferences for clean, safe, and effective solutions. As the market evolves, stakeholders must continue to invest in research and development to unlock the full potential of biopreservation and drive the future of safe, high-quality food and pharmaceutical products.

[tamanna31]

Biopreservation Market by Regions, Type & Applications During 2023-2030

Biopreservation Market Size & Trends

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

PrincetonCryo.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[wellnessweb]

Biopreservation Market Size: Key Drivers and Forecasts

The Biopreservation Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 16.2 billion by 2030 at a CAGR of 28.4% during the forecast period of 2023-2030. The biopreservation market is experiencing rapid growth, driven by advances in biotechnology and increasing demand for personalized medicine. This sector focuses on the preservation of biological samples such as cells, tissues, and organs, utilizing cutting-edge techniques like cryopreservation and vitrification to maintain their viability for extended periods. As the need for reliable storage solutions in biobanking, regenerative medicine, and drug discovery intensifies, companies are innovating with novel cryoprotectants and automated preservation systems. The rise in chronic diseases and the growing emphasis on research and development further propel this market, positioning it as a crucial component in the future of medical and scientific advancements.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/3792

Market Scope & Overview

The report's extensive criteria include an analysis of the leading companies in the market, a study of the knowledge market share, an analysis of the organization's main business lines, product offering, and cost structure, as well as an analysis of current market trends and patterns. In order to research and understand the Biopreservation industry, reliable information sources were used in the examination.

The global market is defined and classified by the market research, which also analyses and foresees regional and global market opportunities. Along with market drivers and restraints, trends, opportunities, and challenges are explored as well. In addition to estimating market quantities for significant categories and geographic regions, the goal of the Biopreservation Market study is to forecast trends and trends for the upcoming years.

Market Segmentation Analysis

By Product

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System

By Application

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

COVID-19 Impact Analysis

Market participants will benefit from the COVID-19 impact study as they develop pandemic preparation plans. The research used both primary and secondary sources of data, in addition to private databases and a paid data source. In this study, the effect of COVID-19 on the Biopreservation Market is examined both globally and domestically. This research considers the indirect effects of the target market on supply and demand.

Regional Outlook

The research focuses on recently developing regional marketplaces where business owners in the industry can find their next venture. The most recent Biopreservation Market study focuses on Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa while also looking closely at other geographical regions.

Competitive Analysis

An overview of the industry, including its definition, uses, and manufacturing processes, is provided in the research report's opening section. The research report then explores the significant players in the global sector. With a focus on the target market, the research study offers an in-depth and thorough examination of the current condition of the Biopreservation Market business. The study contains a substantial amount of market data, making it a valuable resource for businesses and individuals with an interest in the sector.

Key Questions Answered by the Biopreservation Market Report

What global occurrences have influenced the market's expansion as a whole?

What are the most recent developments of the key market participants?

What effects has the conflict between Russia and Ukraine had on the dynamics of the target market?

Conclusion

The Biopreservation Market research report will act as primary tool for market participants and other stakeholders to get complete hold over the market dynamics and device their strategies accordingly.

Read Full Report @ https://www.snsinsider.com/reports/biopreservation-market-3792

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Forensic Technology Industry Trends

Functional Service Providers Industry Trends

Genome Editing Industry Trends

Genomics Services Industry Trends

Genotyping Industry Trends

[latestmarketresearchnews]

Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

Biopreservation Industry 2030 Outlook by Growth Rate, Trends, Size and Opportunities

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the…

[industrynewsupdates]

Biopreservation Market Key Companies, Growth and Forecast Report, 2030

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Marke

Biopreservation Market Report Highlights

• By product, the equipment segment held the largest revenue share of over 78.75% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Increasing demand for modified genetic material in the global market is also fueling the growth

• The bio-banking application segment held the largest revenue share in 2022. This can be attributed to rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals

• North America dominated the global market in 2022 due to the advancement in biomedical research, the development of advanced therapies, and the upsurge in research activities related to DNA sequencing and bioinformatics

• Asia Pacific is expected to grow considerably in the future owing to rising investments in Asian countries and increasing partnerships and collaborations with key players

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

• The global DNA methylation market size was valued at USD 1.47 billion in 2023. It is expected to expand at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2030.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market on the basis of product, application, and region:

Biopreservation Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment

o Freezers

o Refrigerators

o Consumables

o Vials

o Straws

o Microtiter Plates

o Bags

o Liquid Nitrogen

• Media

o Pre-formulated

o Home-brew

• Laboratory Information Management System (LIMS)

Biopreservation Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Regenerative Medicine

o Cell Therapy

o Gene Therapy

o Others

• Bio-banking

o Human Eggs

o Human Sperms

o Veterinary IVF

• Drug Discovery

Biopreservation Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[univdatosmarket]

Biopreservation Market was valued at US$ 5 billion in 2020 and is expected to grow at a CAGR of 14% over the forecast period (2021-2027)